An observational study in Stroke, sponsored by National Rehabilitation Center, Seoul, Korea. Terminated at 2 sites in Korea, Republic of. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-03.
Sponsored by National Rehabilitation Center, Seoul, Korea · Observational
Among 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea — none open to participants now, none under way, none of them phase 3. Stroke · National Rehabilitation Center, Seoul, Korea.
Among the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea, this one is one of 3 that started in 2017, is the only observational one, and was the 20th registered.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
Browse Stroke studies →None of the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea is open now. The open studies under Stroke, anywhere →
Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 3 started in 2017.
This study's enrollment of 46 is below the median of 152 across 1,968 observational studies indexed under Stroke.
Median enrollment 30 across the 19 interventional studies, 46 across the 1 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
National Rehabilitation Center, Seoul, Korea is the lead sponsor of 20 studies on the registry; none are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Reliability and validity of Pittsburgh Rehabilitation Participation Scale during robot therapy among patients with stroke
Those who participated the tethered-robot assisted gait training, had the history of brain lesion and adimitted in the rehabilitation center.
Those who gave the informed consent about this study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No intervention (observational study: The study participants were inpatient and were given robot-assisted gait training routinely.)
Pittsburgh Rehabilitation Participation Scale
Pittsburgh Rehabilitation Participation Scale could be 1 (none), 2, 3, 4, 5, or 6 (excellent). Excellent (6): If the patient participated in all exercises or activities with maximal effort, finished all exercises or activities, and actively took interest in exercises or activities and/or future therapy sessions. None (1): patient refused entire session, or did not participate in any exercises or activities in session. In this study, a participant typically gets 12 sessions of robot assisted gait training. Just after the each session, Pittsburgh Rehabilitation Participation Scale is assigned as 1 to 6. For example, in a virtual case, the participant gets the score of 1, 1, 2, 2, 3, 3, 4, 4, 5, 5, 6, and 6 (median =3.5). the participant gets 12 numbers of outcome score and median of Pittsburgh Rehabilitation Participation Scale.
Time frame: through study completion, an average of 3 year
modified Barthel Index
Modified Barthel Index measures basic activities of daily life. Lowest score is zero and means no function. Highiest score is 100, best function.
Time frame: baseline and 4 weeks from baseline
10m walk
Time frame: baseline and 4 weeks from baseline
Borg scale
Borg scale measures perceived exertion during the test. It ranges 13 to 20. 13 means easy. 20 means hardest.
Time frame: baseline and 4 weeks from baseline
6 min walk
Time frame: baseline and 4 weeks from baseline
motricity index
Time frame: baseline and 4 weeks from baseline
Berg balance scale
Berg balance scale is the combination of 16 5-point-Likert-scale-like ordinal scale of 0 to 4. O means no balance. 56 means the maximal balance as the criteria.
Time frame: baseline and 4 weeks from baseline
Trunk impairment scale
Scores range from a minimum of 0 to a maximum of 23. Zero means no balance. 23 means maximal balance and trunk function.
Time frame: baseline and 4 weeks from baseline
Function in sitting test
Time frame: baseline and 4 weeks from baseline
Modified Rankin Scale for Neurologic Disability
Modified Rankin Scale for Neurologic Disability could be 0, 1, 2, 3, 4, 5, or 6. Zero (0) means no negative symptoms et al as the criteria. 6 means means dead condition (death) as the criteria.
Time frame: baseline and 4 weeks from baseline
Functional Ambulatory Category
Time frame: baseline and 4 weeks from baseline
Timed Timed Up and Go test
Time frame: baseline and 4 weeks from baseline
Manual Muscle Testing
Time frame: baseline and 4 weeks from baseline
modified Ashworth scale
Modified Ashworth scale could be 0, 1, 1+, 2, 3, or 4. Zero (0) means no spasticity as the criteria. 4 means means maximal spasticity as the criteria.
Time frame: baseline and 4 weeks from baseline
National Institutes of Health Stroke Scale
0 to 24 points. Zero (0) means no deficits as the criteria. 24 means means maximal deficits as the criteria.
Time frame: baseline and 4 weeks from baseline
Plan to share: No
Ran from Sep 2017 to primary completion in Oct 2021, 49 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Rehabilitation Center, Seoul, Korea